ABSTRACT
INTRODUCTION
The first Laparoscopic Cholecystectomy (LC) to be performed in the English Speaking Caribbean took place at a private hospital in Trinidad and Tobago in 1991 (1) . To date LC is performed in public hospitals in at least six Caribbean islands but not in Trinidad and Tobago. A recent survey revealed that LC is perceived to be a higher cost procedure than other approaches to cholecystectomy (2) .
The benefits to the patient of having cholecystectomy performed laparoscopically have been well documented (3 -5) and laparoscopy is arguably the future of many commonly performed general surgery procedures (6) . Despite this, even in the private sector, LC has not been widely adopted in Trinidad and Tobago. By 2002, a mere 4% of total (public plus private) cholecystectomies in Trinidad and Tobago were performed laparoscopically (2) . The two main treatment alternatives for uncomplicated gall bladder disease are minilap and open cholecystectomy (MC, OC).
The high initial cost of equipment required to perform LC suggests that this approach to cholecystectomy will represent an increase in cost to the hospital. Some early studies in other countries support this hypothesis (7) while others refute it (8, 9) but no analysis has been published for Trinidad and Tobago. This study compares the cost to the hospital and to society of a laparoscopic programme versus open and minilap strategies for public hospitals in Trinidad and Tobago.
METHODS
A Cost-Minimization Analysis was undertaken based on a clinical decision model using data from published clinical studies, hospital cost data and local (ie Trinidad) clinical practice. Elaborating on an early model (10) , this analysis compares Laparoscopic Cholecystectomy (LC) with Minilaparotomy Cholecystectomy (MC) and Open Cholecystectomy (OC) in terms of costs to the hospital and to society in the form of lost output during convalescence. The health outcomes of the three strategies were considered to be equivalent. The model is displayed in the Figure. tomy can proceed. If the CBD stones are large or if they cannot be flushed it is assumed that an open cholecystectomy with CBD exploration (C2) is performed (P4 = 0.6). Laparoscopic CBD exploration requires special equipment including a choledochoscope, fluoroscopy and laparoscopic dilators. This option is excluded for the purposes of this study. Similarly, Endoscopic Retrograde Cholangio-Pancreaticography (ERCP) is not available at public hospitals in Trinidad and Tobago.
The C3 arm consists of patients with a clear CBD. These patients undergo a basic LC which has a conversion rate to open (C4) of 4.8% (P5 = 0.952 and P6 = 0.048) (11) . Reasons for conversion include difficult anatomy, intraoperative bleeding from CBD injury (12) with a range varying from 2.9% to 6.9% (13) depending on the series used and the how recent the study is.
Mini-lap Approach
Following the minilap branch of the Figure, the first decision involves patient suitability. Morbid obesity, previous upper abdominal surgery and acute cholecystitis are considered to be at least relative contra-indications (14) . Obesity is known to be a predisposing factor for cholelithiasis (15) . Delays in diagnosis (16) together with long waiting lists for elective surgery further increase the theoretical risk of multiple attacks by the time the patient presents for surgery. Quantifying the number of patients in this category in Trinidad and Tobago is impossible given the available data. In the Figure, it is assumed that 30% of patients at the outset will be unsuitable for the minlap approach (P7 = 0.7, P8 = 0.3).
Of the patients that are suitable for the minlap approach, 9.3% are assumed to have a pre-operative diagnosis of CBD stones (10) . These patients undergo OC with IOC (C5). As in the laparoscopic arm of the decision model, the probability that this will be successful is set at 40% (P3 = 0.4 and P4 = 0.6). Unsuccessful patients undergo OC with CBD exploration (C6).
For suitable patients without CBD stones a basic minilap cholecystectomy is performed (C7). A conversion rate to open cholecystectomy of 22% (C8) is used (17) . Patients unsuitable for the mini-lap approach undergo an OC with or without CBD exploration depending on the presence of CBD stones (C9 and C10).
Open Approach
If there is a pre-operative diagnosis of CBD stones, an OC with IOC is performed (C11). As in the minilap and laparoscopic approaches, the probability of success is set at 40% (P3 = 0.4 and P4 = 0.6). For patients with no CBD stones, a basic OC is performed (C13).
Costs
This decision model gives rise to 13 end points (C1 through C13), each of which have different cost profiles. Table 1 shows the cost levels associated with each end-point. The
Pathways and Probabilities
After the decision has been made on the need for a cholecystectomy, a further decision has to be made on the possible presence of common bile duct stones (CBD). This is generally diagnosed pre-operatively with liver function tests and ultrasound evaluation of the biliary tree. The incidence of CBD stones is set at 9.3% (10).
Laparoscopic Approach
For patients with a pre-operative diagnosis of CBD stones (C1 arm), a LC with intra-operative cholangiogram (IOC) is performed. If no stones are found or if small stones are flushed into the duodenum (P3 = 0.4) then the cholecystec- cost associated with each end point comprises hospital costs and costs to society in terms of lost output while the patient is on sick-leave. Only relevant costs are included in this analysis, these are the costs that differ among the various treatment strategies. The hospital costs comprise the following components: $ Operating cost is the cost of the surgery. The cost of operating theatre time is set at TT$1 000 per hour. The operating cost for each pathway is calculated by multiplying the number of minutes for the procedure by TT$16.67 per minute ($1000 per hour). $ Hospital stay: the cost of hospital stay is calculated as TT$800 multiplied by the number of days of stay for each end-point. $ Equipment cost per patient: the cost of the laparoscopic tower from one supplier is quoted as US$28 000. Cheaper equipment is available (from less known brands) and refurbished equipment is available at half of this price. The cost of the laparoscopic instrument set is given as US$8000. It is assumed that the equipment and instruments will have a useful life of 5 years, and are financed by a US$36 000, 5-year 8% government bond. This gives a total cost per year of TT$55 184. Hospital throughput is set at 96 cases per year giving an equipment cost of TT$575 per patient. The cost to society in terms of lost output is calculated by multiplying the average earnings per day by the number of sick leave days for each treatment modality. Earnings data in Table 1 were obtained from the National Accounts Division of the Central Statistical Office of Trinidad and Tobago. Total wages and salaries divided by the number of workers for the year 2000 give an average of TT$45 956 per year = TT$126 per day. Earnings data from official sources are known to be understated (18) so any bias introduced here will be in favour of MC and OC which involve longer periods of sick leave.
Details of the costs incurred in each pathway
Studies dealing with early experience typically show two to four days of hospital stay for LC (9,10) however LC is now routinely performed as ambulatory surgery with hospital stay of less than one day (19, 20) . It is assumed that LC would be The cost end-points in Table 1 can now be multiplied by the respective probabilities to provide the expected values of the relevant costs of each treatment modality. In Table 2 , Table 2 shows that costs to the hospital are lower for the laparoscopic approach than for the other two approaches. This is because the reduced hospital stay overcompensates for the equipment cost per patient. In terms of lost output, the laparoscopic approach saves resources over both the MC and OC regimes. The output losses and hospital costs for the three treatment strategies are brought together in Table 4 to   Table 2 : Hospital costs associated with LC, MC and OC
DISCUSSION

Hospital Cost
Laparoscopic approach = (C1 x P3 x P1) + (C2 x P4 x P1) + (C3 x P5 x P2) + (C4 x P6 x P2) = TT $2759
this is done for hospital costs and Table 3 shows the output lost with each modality. Thus the hospital cost associated with the adoption of LC is given by the expected value of cost end points C1 through C4 in the Figure, ie (C1 x P3 x P1) + (C2 x P4 x P1) + (C3 x P5 x P2) + (C4 x P6 x P2). show the respective total costs to society. Table 5 shows the savings that can be achieved by replacing an MC or OC regime with LC. The potential savings exceed TT$600k per year to the public health sector, and TT$1.4M per year to the economy if an LC programme replaces an OC programme. management would play a critical role in the introduction of laparoscopic general surgery services in public hospitals. A cadre of competent personnel must be developed to support any such initiative. Information systems would also need to be put in place to track the quality of outcomes as well as to monitor variables that will impact on economic outcomes such as operating time and hospital. Under certain conditions, MC is lower in cost than LC. Thus, the lowest cost end-point in the Figure and Table 1 is C7 (straight MC). However, comparing operative regimes, a laparoscopic programme represents cost savings over both MC and OC programmes.
Concerning complications associated with the three approaches to cholecystectomy, early clinical comparisons of LC and OC identified certain complications associated with the former including higher rates of CBD injury (22, 23) . A wide literature suggests that LC is associated with lower morbidity and mortality than OC and attributes the higher rates of CBD injury observed in early reviews to widespread inexperience among surgeons when the procedure was first introduced (13) . Prospective randomized single-blind studies comparing LC with MC found no difference in postoperative complication and mortality rates between these two procedures (24, 25) .
In conclusion, LC saves resources to the health system and other sectors when compared with OC and MC. Hospital morbidity and mortality rates are not adversely affected by LC. Further, LC represents the first stage in the transition to advanced laparoscopic surgery (6) therefore LC represents both a savings opportunity and a development opportunity to the public health system. This paper seeks to evaluate the cost implications of laparoscopic cholecystectomy for public hospitals in Trinidad and Tobago but to achieve these cost savings,
